Tci Wealth Advisors, Inc. Adaptive Biotechnologies Corp Transaction History

Tci Wealth Advisors, Inc.

  • $1.12 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023
BUY
$6.26 - $9.34 $3,092 - $4,613
494 New
494 $3,000
Q2 2022

Jul 19, 2022
SELL
$6.4 - $14.73 $204 - $471
-32 Closed
0 $0
Q1 2022

Apr 29, 2022
BUY
$10.12 - $28.9 $323 - $924
32 New
32 $0
Q1 2021

Apr 29, 2021
SELL
$37.26 - $67.74 $6,706 - $12,193
-180 Closed
0 $0
Q4 2020

Jan 21, 2021
BUY
$45.01 - $65.47 $8,101 - $11,784
180 New
180 $11,000

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email